phase ii trial of enoblituzumab for patients with intermediate/high-risk localised prostate cancer
Published 2 years ago • 302 plays • Length 6:57Download video MP4
Download video MP3
Similar videos
-
6:12
neoadjuvant enoblituzumab for localized prostate cancer
-
4:03
phase i/ii trial of zenocutuzumab for tumors with nrg1 fusions
-
0:56
phase i/ii trial of bms-986365 in mcrpc resistant to arpis
-
1:58
results from phase i/ii study of ds-7300a in advanced solid tumors
-
2:02
unanswered questions regarding the use of parp inhibitors for patients with mcrpc
-
1:30
vbir vaccine shows promise in prostate cancer: phase i trial results and immunotherapy potential
-
0:26
the #rtire trial is now recruiting patients with intermediate-risk prostate cancer.
-
1:54
electronic pathology reporting and clinical trial matching for advanced prostate cancer
-
2:04
results of a phase ii study of lhrh therapy in high-risk prostate cancer
-
1:19
highlights in prostate cancer from esmo
-
1:58
phase ii trial of nivolumab plus ipilimumab in advanced bladder cancer of variant histologies
-
4:03
flame trial
-
12:24
gu asco symposium 2022 summary
-
1:06
imaagen: phase 2 trial of abiraterone acetate for advanced prostate cancer
-
5:21
prospective monitoring of patients with recurrent prostate cancer using serial psma imaging
-
4:06
clinical trial: car-t cell therapy for prostate cancer | mark moyad, md, mph & mark scholz, md
-
1:29
evaluating the role of sbrt in metastatic castrate-resistant prostate cancer
-
3:19
prostate cancer clinical trial: sabre trial
-
20:50
active surveillance 2021 - from bench to bedside